Loading
Latest filing published 06 Mar 2023 for Concert Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James Cassella V is a declared insider of Concert Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 8 filings; the first trade dates from 16 August 2021 and the latest from 6 March 2023.
The open-market record consists of 6 sales worth €168k, with no purchase. Outside the open market, there are 1 share grant. In 2023 alone, the filings show no purchases and 3 sales.
The latest filing, published on 6 March 2023, reports a transaction in Concert Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations